Global Deals
If you would like to discuss a specific subsector or industry please get in touch.
-
BrazilDisposal
Buyer
Deal ByZaxo M&A Partners(Pandea Member Firm)Healthcare & Life Sciences -
BrazilDisposal
Buyer
Deal ByZaxo M&A Partners(Pandea Member Firm)Healthcare & Life Sciences -
BrazilDisposal
Buyer
Deal ByZaxo M&A Partners(Pandea Member Firm)Healthcare & Life Sciences -
BrazilDisposal
Buyer
Deal ByZaxo M&A Partners(Pandea Member Firm)Healthcare & Life Sciences -
MexicoValuation
Deal ByAlea Capital(Pandea Member Firm)Healthcare & Life Sciences -
United KingdomFundraising
Financer
Deal ByDow Schofield Watts(Pandea Member Firm)Healthcare & Life SciencesDSW advised Raphael Healthcare, provider of specialist mental health services for women, on its £6.1m development capital investment from RJD Partners, which valued the company at £30m, before advising on RJD’s exit four years later
-
United KingdomDisposal
Buyer
Deal ByDow Schofield Watts(Pandea Member Firm)Healthcare & Life SciencesDSW advised the shareholders of Techtex, manufacturer of healthcare consumables for care homes and the NHS, on the sale to US-listed Ecolab, global leader in water, hygiene and infection prevention solutions
-
United KingdomDisposal
Buyer
Deal ByDow Schofield Watts(Pandea Member Firm)Healthcare & Life SciencesRoss Care acquisition creates market-leading mobility services group
Ross Care, a major provider of wheelchair services and mobility equipment, has been acquired by Millbrook Healthcare in a deal backed by Cairngorm Capital Partners LLP.
Dow Schofield Watts advised Ross Care on the deal, which will create a national group that is a market leader within the sector. Established in 1949, Ross Careprovides services and equipment on behalf of NHS and local authorities and is the UK’s largest provider of wheelchair repair contracts. Based in Wallasey, it has stores in Manchester, Ellesmere Port, Leeds and Sunderland as well as18 service centres across the North.
Initiated by the retirement of Michael Turner, Ross Care’s Chairman and majority shareholder, the deal will allow both businesses to expand geographically and increase the range of services and benefits they offer. Ross Care’s Managing Director, James Parramore will continue to lead the Ross Care business and will join the executive leadership team of the enlarged group, which will be headquartered in Southampton and have 45 service centres nationwide and 1,200 colleagues delivering over 70 contracts.
Andy Dodd, Gerard Lucas, Callum Sellar and Rachel Green of Dow Schofield Watts provided corporate finance advice to the shareholders of Ross Care.
Michael Turner, Ross Care’s Chairman and majority shareholder, said: “Ross Care has a fantastic heritage and I am extremely proud of all that we have achieved to this point. I know that the company has the capability to achieve much more but this is the natural point for me to pass the company to new, trusted custodians who can deliver on its future potential. In Millbrook, Ross Care has a perfect partner, and together the companies should achieve great things.”
Dr Amit Thaper, who led the Cairngorm Capital team, said: “Ross Care is an excellent company that is highly regarded by its customers and service users. The combination of Ross Care and Millbrook is strategically compelling and delivers additional capabilities and services across the group, to the benefit of all customers. Significant investments are taking place for both businesses and we look forward to supporting Phillip Campling and James Parramore to deliver their growth plan.”
-
United KingdomFundraising
Financer
Deal ByDow Schofield Watts(Pandea Member Firm)Healthcare & Life SciencesDow Schofield Watts Corporate Finance in Yorkshire and North East has advised Bayfields Opticians and Audiologists on its investment from BGF.
Bayfields was founded in 2004 by optometrist Royston Bayfield and has its head office in Esholt. It has grown to 19 practices, including sites in County Durham, Lancashire, Hampshire, Surrey and Yorkshire, with 13 sites acquired within the last four years.
The group currently employs more than 160 staff across the UK and has revenues of £12m.
BGF’s investment will be used to support organic growth – including further roll-out of its audiology services – as well as Bayfields’ strategy to double the number of sites through further acquisitions over the next four years.
Royston Bayfield, founder and chief executive of Bayfields Opticians and Audiologists, said: “In the last 15 years, the Bayfields group has grown exceptionally well, whilst keeping front of mind our values, our local relationships with clients and our high-quality expertise through our expanding team of optometry and audiology specialists.
“We are delighted to be welcoming BGF to the Bayfields family as our long-term investment partner. The team has great sector expertise and a real understanding of our vision for the business, which will be invaluable as we enter this next stage of growth.”
Paul Herriott, corporate finance director at DSW, added: “We have admired Bayfields’ customer proposition and growth ambitions over recent years and are delighted to have advised Royston and the team on securing this important investment. The partnership between Bayfields and BGF will undoubtedly support the business to achieve even greater success in this very specialist and evolving market.”
The DSW team included Paul Herriott, Roger Esler and Bibin Johnson.
-
GermanyAcquisition
Target
Deal BySancovia(Pandea Member Firm)Healthcare & Life Sciences -
SpainAdvisory
Target
Deal ByPKF Attest(Pandea Member Firm)Healthcare & Life Sciences -
United KingdomAcquisition
Deal ByHNH(Pandea Member Firm)Healthcare & Life Sciences -
United KingdomPE
Deal ByHNH(Pandea Member Firm)Healthcare & Life Sciences -
SpainAdvisory
Target
Deal ByPKF Attest(Pandea Member Firm)Healthcare & Life Sciences -
United KingdomAcquisition
Buyer
Deal ByHNH(Pandea Member Firm)Healthcare & Life Sciences -
IndiaAdvisory
Deal ByJRL(Pandea Member Firm)Healthcare & Life Sciences -
SwitzerlandAcquisition
Buyer
Deal BySancovia(Pandea Member Firm)Healthcare & Life Sciences -
United KingdomDisposal
Deal ByDow Schofield Watts(Pandea Member Firm)Healthcare & Life Sciences -
United KingdomGrowth Capital
Deal ByHNH(Pandea Member Firm)Healthcare & Life Sciences -
United KingdomAcquisition
Deal ByHNH(Pandea Member Firm)Healthcare & Life Sciences -
GermanyAcquisition
Target
Deal BySancovia(Pandea Member Firm)Healthcare & Life Sciences